SCHEMBL3483258

SCHEMBL3483258

CCOC(CSc1ccc(C)cc1)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
MAPT P10636 5/20 0.37
RAB9A P51151 4/20 0.37
NPC1 O15118 2/20 0.37
HPGD P15428 5/20 0.36
USP2 O75604 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MAOA P21397 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
THRB P10828 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34
FKBP1A P62942 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1777148 0.83 MAPT (0.35) ALDH1A1MAPTRAB9ANPC1L3MBTL1
SCHEMBL227330 0.83 MAOA (0.55) ALDH1A1RAB9ANPC1MAOAMEN1
SCHEMBL3928142 0.83 MEN1 (0.45) ALDH1A1MAPTRAB9ANPC1HPGD
SCHEMBL17400963 0.83 SLC6A4 (0.37) L3MBTL1TDP1MAOAMAPK1
SCHEMBL12135641 0.82 MAOA (0.52) ALDH1A1MAPTRAB9ANPC1HPGD
SCHEMBL17400964 0.81 APP (0.44) ALDH1A1RAB9ANPC1MAOAMEN1
SCHEMBL7423260 0.80 NPC1 (0.39) ALDH1A1MAPTRAB9ANPC1HPGD
SCHEMBL3812917 0.79 MAOA (0.38) ALDH1A1RAB9ANPC1MAOAKMT2A
SCHEMBL13286840 0.76 ALDH1A1 (0.43) ALDH1A1MAPTHPGDNPSR1MEN1
SCHEMBL6978225 0.76 PPARD (0.35) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016000599-A1 C-BENZO FIVE-MEMBERED HETEROAROMATIC RING ARYL GLUCOSIDE DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海阳帆医药科技有限公司 2016-01-07 WO disclosed
EP-2049200-B1 NOVEL INHIBITORS OF BETA-LACTAMASE METHYLGENE INC (CA) 2015-04-29 EP disclosed
US-8440643-B2 Inhibitors of beta-lactamase METHYLGENE INC. (CA) 2013-05-14 US disclosed
US-20100279983-A1 NOVEL INHIBITORS OF BETA-LACTAMASE METHYLGENE INC. 2010-11-04 US disclosed
EP-2049200-A2 NOVEL INHIBITORS OF BETA-LACTAMASE MethylGene Inc. (CA) 2009-04-22 EP disclosed
WO-2008073142-A2 NOVEL INHIBITORS OF BETA-LACTAMASE MERCK & CO., INC. (US) 2008-06-19 WO disclosed
US-20080021026-A1 BENZOTHIOPHENE INHIBITORS OF RHO KINASE Kahraman, Mehmet (US) 2008-01-24 US disclosed
US-4611059-A THROMBOXANE A2(TXA2) SYNTHETASE INHIBITORS THE UPJOHN COMPANY (US) 1986-09-09 US disclosed
EP-0069521-A2 Pyridinyl and imidazolyl derivatives of benzofurans and benzothiophenes THE UPJOHN COMPANY (US) 1983-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021026-A1 BENZOTHIOPHENE INHIBITORS OF RHO KINASE RHOT2, ROCK2, ROCK1 ALDH1A1 3500/4885MAPT 551/4885RAB9A 830/4885
US-20100279983-A1 NOVEL INHIBITORS OF BETA-LACTAMASE MGAM, MGAM2, PGLS ALDH1A1 2190/4885MAPT 3993/4885RAB9A 972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.